Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer

NCT00006486 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

335

Enrollment

NIH

Sponsor class

Conditions

Recurrent Renal Cell Cancer
Stage IV Renal Cell Cancer

Interventions

DRUG: carboxyamidotriazole
OTHER: placebo

Sponsor

National Cancer Institute (NCI)